Collectively, our results and those of previous studies suggest that enhancement of the CSC’s stemness properties by Oct3/4 and Nanog expression may also contribute to cancer progression, including the development of DNM, together with the elevated cell motility associated with EMT. This evidence concerns the gene POU5F1 and cancer.